Analyzing Halberd (HALB) & The Competition
Halberd (OTCMKTS:HALB – Get Rating) is one of 343 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to similar companies based on the strength of its valuation, earnings, profitability, risk, analyst recommendations, institutional ownership and dividends. Insider & Institutional Ownership 22.3% of shares […]